Last deal

$2.7M

Amount

Series A

Stage

17.06.2021

Date

1

all rounds

$2.7M

Total amount

General

About Company
Vectron Biosolutions develops and markets vector technologies for the biotechnology and life science industries.

Industry

Sector :

Subsector :

founded date

19.05.2008

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

The company offers a range of vector technologies, including bacterial cloning vectors and expression vectors engineered for recombinant protein production in bacteria. They also provide customized vectors for specific applications and recombinant proteins. In addition, Vectron offers protein production, vector design, and molecular engineering services to support life science research activities. Their technology uses an inducible promoter to develop bacterial strains that produce proteins at the right titers and with the right quality, resulting in increased yield and solubility of therapeutic proteins. Vectron Biosolutions aims to develop robust and cost-efficient microbial protein production processes for their clients.
Contacts